home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

211 rows where filing_period = "fourth_quarter", filing_year = 2012 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, income_amount, is_termination, received_date (date)

issue_code 1

  • PHA · 211 ✖

filing_year 1

  • 2012 · 211 ✖

filing_period 1

  • fourth_quarter · 211 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1329619 AMERICAN COLLEGE OF CLINICAL PHARMACY e1bb6e4e-81f9-4427-b926-bb81faaf2481 Q4 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2012 fourth_quarter PHA Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   61700 0 0 2012-12-18T12:19:09.790000-05:00
1330174 CYBER SECURITY RESEARCH CONSULTANTS, LLC ab748300-1b4f-429b-821a-c80d4b6985e5 Q4 CYBER SECURITY RESEARCH CONSULTANTS, LLC 91694 PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION 2012 fourth_quarter PHA Monitoring Drug Importation from Canada, including McCain amendment to FDA Reauthorization Act HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-01-01T13:38:22.597000-05:00
1331094 UNIVERSITY OF IOWA d3288b05-e711-4dc0-a520-6b35f98e3f24 Q4 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2012 fourth_quarter PHA Increased appropriations for systems to shorten the time between development of a drug and its release to the public FDA reform as it relates to drug development and research FDA User Fee Bill Collaborative research on drug development anti-malarial pharmaceuticals FY 2011 Agricultural Appropriations human factors research related to neuropharmaceuticals Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)   28999 0 0 2013-01-07T09:54:07.577000-05:00
1331148 NAHIGIAN STRATEGIES, LLC fdbe95ab-b2ce-46b2-908d-83bec81e170a Q4 NAHIGIAN STRATEGIES, LLC 322897 TEVA PHARMACEUTICALS USA INC 2012 fourth_quarter PHA No specific bill number. Monitoring. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-01-07T10:55:48.410000-05:00
1331261 INJURED WORKERS PHARMACY 7c10b7e5-360b-4e3d-99c6-c7f03fd39bfa Q4 INJURED WORKERS PHARMACY 400765309 INJURED WORKERS PHARMACY 2012 fourth_quarter PHA Transparency of Pharmacy Benefit Managers (bill sponsored by Rep. McMorris-Rodgers and Senator Mark Pryor); Longshoreman and Harbor Workers Amendment Act of 2011 sponsored by Senator Isakson. HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-01-07T15:31:46.697000-05:00
1331629 INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) 6595ce65-25d0-4bc7-a228-9d98688f8f50 Q4 INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) 400337570 INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) 2012 fourth_quarter PHA All issues affecting the compounding sector of the pharmacy industry Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   20000 0 0 2013-01-08T15:52:33.700000-05:00
1331653 DUTKO WORLDWIDE, LLC 67470ed2-937c-4f9e-857f-dfc07db036f1 Q4 DUTKO WORLDWIDE, LLC 12868 NEWAYS INTERNATIONAL 2012 fourth_quarter PHA Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (PL 111-353) and Patient Protection and Affordable Care Act (PL 111-148). Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-01-08T16:20:47.577000-05:00
1332397 RED+BLUE STRATEGIES 672108ca-e43e-46c3-b742-7945c9334548 Q4 RED+BLUE STRATEGIES 400693064 EXPRESS SCRIPTS INC. 2012 fourth_quarter PHA H.R. 1946 - Preserving Our Hometown Independent Pharmacies Act of 2011, which creates and antitrust exemption for certain pharmacies. Rules, regulations and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy. Issues impacting PBMs included in the Prescription Drug User Fee Act reauthorization and the Generic Drug User Fee Reauthorization. Policies related to stopping the diversion of prescription medications in the nation's drug supply chain. Changes in International Naming policies for generic medications. Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2013-01-10T15:02:51.520000-05:00
1332662 GREATER NEW YORK HOSPITAL ASSOCIATION 7d334df5-68da-46ba-812f-810b3f060568 Q4 GREATER NEW YORK HOSPITAL ASSOCIATION 16830 GREATER NEW YORK HOSPITAL ASSOCIATION 2012 fourth_quarter PHA Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including drug shortage legislation (S. 296, H.R. 2245), potential drug shortage legislation, potential price gouging legislation, medical device pricing issues, and preserving access to group purchasing organizations; The Food and Drug Administration Safety and Innovation Act (S.3187); issues related to unique device identification; issues related to drug compounding overisth by Congress; issues related to group purchasing organizations and a letter sent by Congressman Markey regarding drug shortages. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   220000 0 0 2013-01-11T09:04:08.330000-05:00
1332793 PARRY, ROMANI, DECONCINI & SYMMS 5e7064db-a4c3-4f3c-9c55-0060b2f14058 Q4 PARRY, ROMANI, DECONCINI & SYMMS 30792 POZEN, INC. 2012 fourth_quarter PHA To provide incentives for new drug development. No specific bills pending. HOUSE OF REPRESENTATIVES,SENATE 36000   0 0 2013-01-11T11:32:05.333000-05:00
1332798 RED+BLUE STRATEGIES 4a2d9204-0621-461f-b204-c47da7dff798 Q4 RED+BLUE STRATEGIES 400693064 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2012 fourth_quarter PHA H.R. 1946 - Preserving Our Hometown Independent Pharmacies Act of 2011, which allows for an antitrust exception for certain pharmacies. Issues related to the practice of giving coupons for certain prescription medications. S. 3187 - FDA Safety and Innovation Act - Issues related to supply chain safety, treatment of controlled substances and REMS policies. H.R. 4310 - National Defense Authorization Act for 2013 - Issues related to the utilization of mail order pharmacy for Tricare beneficiaries. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2013-01-11T11:35:07.770000-05:00
1332836 UPS (UNITED PARCEL SERVICE) 51a619d8-fec0-4169-933a-fbb4517dca68 Q4 UPS (UNITED PARCEL SERVICE) 39223 UPS (UNITED PARCEL SERVICE) 2012 fourth_quarter PHA - HR 2405 / S.1855 Healthcare Supply Chain Safety - track and trace in the Prescription Drug Users Fee Act - Pandemic All Hazards Preparedness Act (PAHPA) Commerce, Dept of (DOC),Federal Aviation Administration (FAA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),Natl Transportation Safety Board (NTSB),Postal Regulatory Commission,SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Treasury, Dept of,U.S. Trade Representative (USTR)   1401414 0 0 2013-01-11T12:12:20.473000-05:00
1332943 VAN HEUVELEN STRATEGIES, LLC fadb8fe5-d70d-4b22-a7a0-7fc0555331ee Q4 VAN HEUVELEN STRATEGIES, LLC 321874 CVS HEALTH (FORMERLY KNOWN AS CVS CAREMARK) 2012 fourth_quarter PHA Issues related to prescription drug abuse, drug supply chain safety and prescriber education. H.R.2119, Ryan Creedon Act of 2011 HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2013-01-11T13:45:21.560000-05:00
1333099 VAN HEUVELEN STRATEGIES, LLC aa5f0569-5a0f-46d2-bb31-1e7cef95125e Q4 VAN HEUVELEN STRATEGIES, LLC 321874 DAVITA 2012 fourth_quarter PHA Provisions pertaining to kidney care, dialysis, Medicare, Medicaid, CMS reimbursement issues, and health insurance. Implementation of Patient Protection and Affordable Care Act. Implementation of the Budget Control Act. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2013-01-11T15:33:27.127000-05:00
1333145 PARRY, ROMANI, DECONCINI & SYMMS 170a0ee3-5e21-4b86-a25c-fd843091a9d8 Q4 PARRY, ROMANI, DECONCINI & SYMMS 30792 BRAIDWOOD MANAGEMENT, INC. 2012 fourth_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11810   0 0 2013-01-11T16:15:47.747000-05:00
1333162 PARRY, ROMANI, DECONCINI & SYMMS 4cb22445-177f-4a35-a5f7-44543a74c592 Q4 PARRY, ROMANI, DECONCINI & SYMMS 30792 DIAMONDBACK DRUGS 2012 fourth_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 6000   0 0 2013-01-11T16:28:55.587000-05:00
1333192 HAAKE & ASSOCIATES 1b43e0be-9fc2-4835-9f8f-69faa9bee11d Q4 HAAKE & ASSOCIATES 17226 JOHNSON & JOHNSON SERVICES INC. 2012 fourth_quarter PHA Policy and procurement matters related to vaccines Army, Dept of (Other),Defense, Dept of (DOD),Defense Logistics Agency,HOUSE OF REPRESENTATIVES,Navy, Dept of,SENATE,U.S. Marines 20000   0 0 2013-01-11T16:48:08.780000-05:00
1333216 PARRY, ROMANI, DECONCINI & SYMMS 3998ff24-8382-4c35-b48e-ff8de2a41c8a Q4 PARRY, ROMANI, DECONCINI & SYMMS 30792 VETERINARY PHARMACIES OF AMERICA, INC. 2012 fourth_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2013-01-11T17:20:17.140000-05:00
1333230 PARRY, ROMANI, DECONCINI & SYMMS fc6d79a6-2be9-46ad-9911-8cf8890c8237 Q4 PARRY, ROMANI, DECONCINI & SYMMS 30792 WEDGEWOOD VILLAGE PHARMACY, INC. 2012 fourth_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. Regulatory issues involving compounded 17P and compounded Avastin. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2013-01-11T17:36:22.430000-05:00
1333236 PARRY, ROMANI, DECONCINI & SYMMS 57cc1ce0-ea5b-4f21-ba85-297ae6727a6a Q4 PARRY, ROMANI, DECONCINI & SYMMS 30792 WOMEN'S INTERNATIONAL PHARMACY, INC. 2012 fourth_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. Regulatory issues involving compounded 17P. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2013-01-11T17:46:26.020000-05:00
1333382 SQUIRE PATTON BOGGS b232619b-02f7-4c7d-bb07-d3f09ed4968a Q4 SQUIRE PATTON BOGGS 30906 SUNOVION PHARMACEUTICALS INC 2012 fourth_quarter PHA Issues related to inclusion of six protected classes within Essential Health Benefit. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2013-01-12T06:12:40.407000-05:00
1333413 HEARTLAND SOLUTIONS GROUP, INC. b168f0bb-7e03-462a-bb3e-fde2648071e3 Q4 HEARTLAND SOLUTIONS GROUP, INC. 312133 ZEBRA TECHNOLOGIES CORPORATION 2012 fourth_quarter PHA Any and all issues related to barcode, secure identification and real-time location systems. HOUSE OF REPRESENTATIVES,SENATE 41250   0 0 2013-01-12T15:38:55.910000-05:00
1333539 FLYNN & ASSOCIATES, INC. 796191e6-643f-4aee-8506-553f72a4d225 Q4 FLYNN & ASSOCIATES, INC. 15020 PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION 2012 fourth_quarter PHA TPP Negotiations Medicare Part-D rebates Pharmaceutical industry employment issues HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2013-01-13T19:37:17.947000-05:00
1333866 MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) 18e98863-0b26-4815-9dfa-fbdc041abab7 Q4 MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) 24486 ALLIED MEDICAL SUPPLY, INC. 2012 fourth_quarter PHA Issues affecting resellers of pharmaceutical products HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2013-01-14T12:24:09.553000-05:00
1334063 MERCURY PUBLIC AFFAIRS, LLC 125a00f4-7078-4489-8bb8-a28db441523d Q4 MERCURY PUBLIC AFFAIRS, LLC 70175 EXPRESS SCRIPTS INC. 2012 fourth_quarter PHA Prescription drug monitoring. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2013-01-14T13:58:52.177000-05:00
1334359 MARTIN & SEIBERT, L.C. 26c60848-8051-497d-9b7a-d6a1b657eb53 Q4 MARTIN & SEIBERT, L.C. 400970784 EXPRESS SCRIPTS 2012 fourth_quarter PHA General education and discussion relating to tracking of drugs HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-01-14T16:41:05.060000-05:00
1334509 AMERICAN AMBULANCE ASSOCIATION 595113de-5c13-486b-9884-ab4d638faa8c Q4 AMERICAN AMBULANCE ASSOCIATION 56018 AMERICAN AMBULANCE ASSOCIATION 2012 fourth_quarter PHA Supported efforts to address the drug shortage issue as it pertains to emergency medical service providers. Centers For Medicare and Medicaid Services (CMS),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE,Veterans Affairs, Dept of (VA)   260000 0 0 2013-01-14T17:26:16.857000-05:00
1334568 VAN NESS FELDMAN, LLP 9dcd0491-96ba-4be7-b70d-eb877781f7d3 Q4 VAN NESS FELDMAN, LLP 39815 SONOMA COUNTY WATER AGENCY 2012 fourth_quarter PHA Issues related to the safe disposal of unused prescription medicines Army, Dept of (Corps of Engineers),Council on Environmental Quality (CEQ),Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),Office of Management & Budget (OMB),SENATE,U.S. Fish & Wildlife Service (USFWS),U.S. Geological Survey (USGS) 20000   0 0 2013-01-14T20:06:37.477000-05:00
1334741 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 411635ea-0407-44f7-96de-73113c101259 Q4 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2012 fourth_quarter PHA Rx Pedigree (H.R. 3026/PL 112-144); NASPER Reauthorization (H.R. 866); Prescription Drug Monitoring Programs (S. 2254/H.R. 4292/PL 112-144); Pill Mill Crackdown Act (H.R. 1065/S. 1760/S. 2297); Drug Abuse (S. 507); Drug Shortages (S. 296/HR 2245/HR 3839/ PL 112-144/HR 5853/HR 5651); Cargo/Product Theft (S. 1002/H.R. 4223; PL 112-204); Counterfeit Drugs (S. 1886/H.R. 3668/PL 112-144) Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   228000 0 0 2013-01-15T10:08:19.353000-05:00
1335147 SHELTER ROCK STRATEGIES, LLC 72192c9c-3b21-4b70-98d1-80677d23574e Q4 SHELTER ROCK STRATEGIES, LLC 400772326 NEW YORK MEDICAL COLLEGE 2012 fourth_quarter PHA BARDA Solicitation HHS 11-100SOL-00011, Centers for Innovation in Advanced Development and Manufacturing, Assess the likelihood this solicitation will get funded, assess competition, assist in writing and getting signed memoranda of support from the NY Congressional Delegation, and assist in obtaining support from NY State to aide the client's proposal. SENATE     0 0 2013-01-15T12:49:58.037000-05:00
1335295 LNE GROUP 23753ad4-a96c-4019-af28-27fcecee0ab9 Q4 LNE GROUP 308811 OHIOGUIDESTONE (FORMALLY KNOWN AS GUIDESTONE) 2012 fourth_quarter PHA Lobbied on pharmacy issues HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-01-15T13:45:01.707000-05:00
1335377 LNE GROUP ccaac859-1ebc-491c-bd49-0ddd2426620d Q4 LNE GROUP 308811 INTRINSIQ MATERIALS 2012 fourth_quarter PHA Lobbied on pharmacy issues HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-01-15T14:10:31.830000-05:00
1335432 FAEGRE BAKER DANIELS CONSULTING 4b11bb61-b505-4b93-9b36-b07de4f27ae1 Q4 FAEGRE BAKER DANIELS CONSULTING 34158 ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP) 2012 fourth_quarter PHA Online pharmacies - S. 2002 and HR 4095 Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 5000   0 0 2013-01-15T14:23:53.677000-05:00
1335465 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 294873e1-7251-407a-b037-148748d33dfe Q4 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 THE HEMOPHILIA ALLIANCE 2012 fourth_quarter PHA Issues realted to the 340B drug discount program. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-01-15T14:30:09.410000-05:00
1335477 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 3c5e2db8-a8d1-4179-9445-96ae0d33be86 Q4 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL HEMOPHILIA FOUNDATION 2012 fourth_quarter PHA Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2013-01-15T14:33:14.787000-05:00
1335534 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 48077c00-4a3e-4425-82b0-1ee65de6f394 Q4 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN SOCIETY OF HEMATOLOGY 2012 fourth_quarter PHA Issues related to drug shortages. FDA Safety and Innovation Act. Public Law 112-144. Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2013-01-15T14:37:29.317000-05:00
1335636 MR. VINCENT A. PANVINI d0a5e85b-729f-46da-a42a-068c0da8587d Q4 MR. VINCENT A. PANVINI 401008845 PHRMA 2012 fourth_quarter PHA Medicare Part D, TransPacific Partnership (TPP) SENATE     0 0 2013-01-15T15:21:08.017000-05:00
1335647 MR. VINCENT A. PANVINI c4e44364-f7e2-4a98-a845-f65b24c8c4c0 Q4 MR. VINCENT A. PANVINI 401008845 ELI LILLY AND COMPANY 2012 fourth_quarter PHA Medicare Part D, TransPacific Partnership (TPP) SENATE     0 0 2013-01-15T15:31:09.140000-05:00
1335855 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 2b7f1516-e03f-4f72-8b14-b6940e5a3287 Q4 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL ASSOCIATION OF EPILEPSY CENTERS 2012 fourth_quarter PHA Issues related to anti-epileptic drugs. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2013-01-15T16:27:09.030000-05:00
1336322 VENABLE LLP 5b162ffe-78f1-4806-a6dc-612052d0a3e3 Q4 VENABLE LLP 39941 ENDO PHARMACEUTICALS INC 2012 fourth_quarter PHA General issues affecting the pharmaceutical industry and bioequivelence. (Generic pharmaceutical user fee act; H.R. 5651.) The Life Sciences Jobs and Investment Act (S. 1410; H.R. 2632) HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2013-01-16T10:07:51.857000-05:00
1336407 DENNY MILLER ASSOCIATES df308f88-dcd8-441d-b301-dc803d5a8536 Q4 DENNY MILLER ASSOCIATES 25328 CELL THERAPEUTICS 2012 fourth_quarter PHA Issues related to prescription drug development. SENATE 30000   0 0 2013-01-16T10:43:32.450000-05:00
1336533 GRIZZLE COMPANY 8e162bff-ccec-4ad5-9569-aa71289c843a Q4 GRIZZLE COMPANY 16987 KENTUCKYONE HEALTH (FORMERLY JEWISH HOSPITAL HEALTH CARE SERVICES) 2012 fourth_quarter PHA Express support to FDA for need of low cost generics without compromising safety measures for tamper resistance. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-01-16T11:21:39.450000-05:00
1336706 WHITMER & WORRALL, LLC e259115e-02e5-4a24-9b68-c31843ff1c07 Q4 WHITMER & WORRALL, LLC 292892 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2012 fourth_quarter PHA Issues related to monitoring healthcare reform. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-01-16T11:49:10.807000-05:00
1336893 INDEPENDENT PHARMACY COOPERATIVE 59b01ce7-2485-45a7-84ff-cb1e180a157d Q4 INDEPENDENT PHARMACY COOPERATIVE 313098 INDEPENDENT PHARMACY COOPERATIVE 2012 fourth_quarter PHA Potential prescription drug track-and-trace legislation. RxTEC Drug Compounding Hearings HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-01-16T12:35:36.117000-05:00
1337067 CAPITOL HILL CONSULTING GROUP 33138698-ad7b-4959-a86a-4057cf53efb3 Q4 CAPITOL HILL CONSULTING GROUP 72053 PURDUE PHARMA LLP 2012 fourth_quarter PHA Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act (H.R. 1316) Stop Tampering of Prescription Pills Act of 2012 (H.R. 6160) HOUSE OF REPRESENTATIVES,SENATE 15750   0 0 2013-01-16T13:20:59.183000-05:00
1337422 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS faac12a7-76d2-47e4-a013-98f8e11b10e7 Q4 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 3457 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 2012 fourth_quarter PHA H.R. 6413, support for the "Transitional Care Act of 2012." Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communication to FDA on approval of biosimilars and drug safety. Communications to Health Resources and Services Administration on 340B drug discount program. Communication with FDA and Centers for Disease Control and Prevention on compounding.Provided input on H.R. 6584, "Verifying Authority and Legality In Drug Compounding Act of 2012." Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   250000 0 0 2013-01-16T15:19:27.137000-05:00
1337594 RED+BLUE STRATEGIES bba9ca33-5113-4ac1-947c-fe85dfba0c21 Q4 RED+BLUE STRATEGIES 400693064 PEW CHARITABLE TRUSTS 2012 fourth_quarter PHA H.R. 2182/S. 1734 - Generating Antibiotic Incentives Now Act . Supporting work to increase innovation and development of new antibiotics. S. 1584 - Drug Safety and Accountability Act- Supporting legislation and related Congressional activity regarding upstream supply stream safety. H.R. 3026- Safeguarding America's Pharmaceuticals Act. Supporting legislation and congressional activity regarding downstream supply chain safety. S. 3187 - The FDA Safety and Innovation Act- specific work on antibiotic innovation, up and down stream supply chain issues, and medical device policies. Policies related to the growing concerns regarding drug shortage issues in hospitals across the country. Potential language related to Track and Trace provisions regarding downstream supply chain safety being considered by the Senate HELP and House Energy and Commerce Committees. H.R. 6584 The Valid Compounding Act - Providing input regarding safe standards and practices for compounding pharmacies H.R. 6638 - S.A.F.E Compounded Drugs Act - Providing input regarding safe standards and practices for compounding pharmacies H.R. 8 - The American Taxpayer Relief Act of 2012- Focused on provisions that could have an impact on the nation's public health system. Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-01-16T15:43:35.230000-05:00
1337630 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 08d06434-99f4-4342-86c5-79c820e1d695 Q4 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 29403 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2012 fourth_quarter PHA Pseudoephedrine Pseudoephedrine - potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient, common in popular cold and allergy medications (no bill number) and oppose prescription requirement (no bill number). Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE   150000 0 0 2013-01-16T15:47:48.270000-05:00
1337912 OCHSNER CLINIC FOUNDATION cfed2529-6249-4aa7-b595-3b4d47fb832e Q4 OCHSNER CLINIC FOUNDATION 45391 OCHSNER CLINIC FOUNDATION 2012 fourth_quarter PHA S. 296 A bill to amend the Federal Food, Drug, and Cosmetic Act to provide the Food and Drug Administration with improved capacity to prevent drug shortages. All Provisions. H.R. 6611 Patient Access to Drugs In Shortage Act. All Provisions Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   160000 0 0 2013-01-16T16:42:43.497000-05:00
1338097 KNIGHT CAPITOL CONSULTANTS f81586f9-27ec-4599-997e-efce1e7667e5 Q4 KNIGHT CAPITOL CONSULTANTS 40036301 GENZYME CORPORATION 2012 fourth_quarter PHA S. 606, Creating Hope Act of 2011, S. 296/H.R. 2245, Preserving Access to Life-Saving Medications Act, The Food and Drug Administration Safety and Innovation Act (PL 112-144) and amendments considered, including the Faster Access to Specialized Treatments Act (H.R. 4132) and the Transforming the Regulatory Environment to Accelerate Access to Treatment (TREAT) Act (S. 2113). Assess potential impact of sequestration on public health/food and drug programs (HR 8/PL 112-240). HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2013-01-16T17:26:05.230000-05:00
1338205 HANCE SCARBOROUGH 1f24742d-a832-409c-a205-13c2405ce040 Q4 HANCE SCARBOROUGH 17443 INTRATHECAL CUSTODY ACCOUNT SUPPORTERS (INFORMAL COALITION) 2012 fourth_quarter PHA Monitored legislation related to physician control and patient access to intrathecal pump applications for patients with chronic pain. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2013-01-16T18:02:51.480000-05:00
1338225 HANCE SCARBOROUGH fb06d9ae-3917-4c61-ba1c-24443cdf452f 4T HANCE SCARBOROUGH 17443 TEXAS ACADEMY OF COMPOUNDING PHARMACISTS 2012 fourth_quarter PHA Federal legislation affecting the practice of pharmacy and FDA regulation of compounded drugs. HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2013-01-16T18:10:58.837000-05:00
1338373 GREENBERG TRAURIG, LLP d3970048-93b9-4559-b1bf-d200b522b2be Q4 GREENBERG TRAURIG, LLP 16896 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA) 2012 fourth_quarter PHA Health care legislative and regulatory issues affecting independent community pharmacies. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB) 30000   0 0 2013-01-17T08:09:18.907000-05:00
1338518 EMPIRE CONSULTING GROUP 7df9cbcb-27fa-48cf-bf82-f79a91f6a23b Q4 EMPIRE CONSULTING GROUP 400703105 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2012 fourth_quarter PHA "Dual eligibles" (Medicare-Medicaid) issues; and Medicare Prescription Drug Act issues; health disparities in minority communities; and issues relating to the Medicare Prescription Drug Act and the Patient Protection & Affordable Care Act. HOUSE OF REPRESENTATIVES 30000   0 0 2013-01-17T09:39:32.827000-05:00
1338661 VORYS ADVISORS, LLC 1cf113fc-22ea-44b9-af0f-ea5fdb66e025 Q4 VORYS ADVISORS, LLC 400873558 AMERISOURCEBERGEN CORPORATION 2012 fourth_quarter PHA Various health care proposals HOUSE OF REPRESENTATIVES     0 0 2013-01-17T10:25:42.043000-05:00
1338695 MEHLMAN CONSULTING, INC. 1c055eab-3913-45cf-af64-17be87a2fade Q4 MEHLMAN CONSULTING, INC. 284950 PROCTER & GAMBLE 2012 fourth_quarter PHA Preventing Abuse of Cough Treatments Act of 2012 (S. 3376) Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2013-01-17T10:32:59.293000-05:00
1338796 BLUECROSS BLUESHIELD OF TENNESSEE 44b41d66-0343-4349-9938-d83ff22c427a Q4 BLUECROSS BLUESHIELD OF TENNESSEE 6440 BLUECROSS BLUESHIELD OF TENNESSEE 2012 fourth_quarter PHA General Pharmacy Issues HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2013-01-17T10:56:46.183000-05:00
1338863 ELI LILLY AND COMPANY 43892ce7-1096-4bdb-9f10-70ab9b4d78f9 Q4 ELI LILLY AND COMPANY 13392 ELI LILLY AND COMPANY 2012 fourth_quarter PHA Hospital discounts (HR 3590) Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Food & Drug Administration (FDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR)   2055000 0 0 2013-01-17T11:16:18.230000-05:00
1338983 LONG TERM CARE PHARMACY ALLIANCE 5e486993-cd89-42aa-a513-c62050321cc2 Q4 LONG TERM CARE PHARMACY ALLIANCE 400309443 LONG TERM CARE PHARMACY ALLIANCE 2012 fourth_quarter PHA Medicare Part D Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   201000 0 0 2013-01-17T11:47:17.700000-05:00
1339206 THORSEN FRENCH ADVOCACY LLC 22648f5f-2873-448d-99f2-3a0f021a0e0c Q4 THORSEN FRENCH ADVOCACY LLC 400599826 ASTRAZENECA PHARMACEUTICALS LP 2012 fourth_quarter PHA Issues realted to access to pharmaceuticals. HOUSE OF REPRESENTATIVES 10000   0 0 2013-01-17T12:38:00.513000-05:00
1339536 FOOD MARKETPLACE INC. 4a74ec0a-4674-41de-8d4b-7ed2836ae2aa Q4 FOOD MARKETPLACE INC. 15097 FOOD MARKETPLACE INC 2012 fourth_quarter PHA H.R. 1406 - Fairness to Pet Owners Act of 2011 S. 3376 - Preventing Abuse of Cough Treatments Act Agriculture, Dept of (USDA),Executive Office of the President (EOP),Federal Reserve System,Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA),Treasury, Dept of,White House Office   160000 0 0 2013-01-17T13:52:04.213000-05:00
1339700 KENT & O'CONNOR, INC. eae8d362-5be3-4f2c-ad23-6c6b16f98284 Q4 KENT & O'CONNOR, INC. 21426 INTERNATIONAL WAREHOUSE LOGISTICS ASSOCIATION 2012 fourth_quarter PHA Legislation and regulations relating to drug safety issues. Consumer Product Safety Commission (CPSC),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Natl Labor Relations Board (NLRB),SENATE,Surface Transportation Board (STB),Transportation, Dept of (DOT),Transportation Security Administration (TSA),U.S. Customs & Border Protection 20000   0 0 2013-01-17T14:18:17.927000-05:00
1340276 TARPLIN, DOWNS & YOUNG, LLC 41b17573-b001-49b3-b181-b9f3bfa040e7 Q4 TARPLIN, DOWNS & YOUNG, LLC 304736 HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) 2012 fourth_quarter PHA **see addendum page Importation of prescription drugs (S.319/H.R. 147) NASPER reauthorization (H.R. 866) Pill Mill Crackdown Act (H.R. 1065/S. 1760/S. 2297) Drug Abuse (S. 507) Drug Shortages (S. 296/H.R. 2245/H.R. 3839/PL 112-144/H.R. 5853/H.R. 5651) Rx Pedigree (H.R. 3026/PL 112-144) Cargo/Product Theft (S. 1002/H.R. 4223) Prescription Drug Monitoring Program (H.R. 2254/H.R. 4292/PL 112-144) Counterfeit Drugs (S. 1886/H.R. 3668/PL 112-144) ***, no specific bills, supply chain integrity, prescription drug abuse Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2013-01-17T15:27:08.213000-05:00
1340553 AMERICAN ADVERTISING FEDERATION b9bd2f38-c444-46d8-bab9-3ab8afff00d0 Q4 AMERICAN ADVERTISING FEDERATION 1411 AMERICAN ADVERTISING FEDERATION 2012 fourth_quarter PHA Proposals to limit or restrict direct-to-consumer advertising of pharmaceuticals Proposals to require a moratorium on the advertising of new prescription medicines Proposals to extend the Food and Drug Administration authority for the advertising of over-the-counter medications HR 741 To amend the Federal Food, Drug and Cosmetic Act to prohibit the marketing of authorized generic drugs H.Res. 343 Disapproving the Supreme Courts decision in Sorrell v. IMS Health Oppose proposals to add overly-burdensome product warnings to DTC advertising Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Telecommunications & Information Administration (NTIA),SENATE   20000 0 0 2013-01-17T16:11:02.367000-05:00
1340618 AMERICAN SOCIETY OF CONSULTANT PHARMACISTS 35ea81f8-bcf8-4691-96db-aead8d690b45 Q4 AMERICAN SOCIETY OF CONSULTANT PHARMACISTS 3446 AMERICAN SOCIETY OF CONSULTANT PHARMACISTS 2012 fourth_quarter PHA S. 1560, the "Nursing Home Resident Pain Relief Act of 2011," H.R. 6413, the "Medicare Transitional Care Act of 2012," S. 3604, the "Improving Dementia Care Treatment in Older Adults Act," implementation of electronic Health Information Technology (HIT) requirements HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-01-17T16:21:01.287000-05:00
1340679 THE MATHIS HARPLE GROUP c4e25117-f101-43d3-8ffc-9f7891e0440c Q4 THE MATHIS HARPLE GROUP 322911 PILMA 2012 fourth_quarter PHA Medicare Part D, Patent Protection, TransPacific Partnership Agreement HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-01-17T16:28:59.523000-05:00
1340968 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION bbe9a1b1-4e0d-4e04-915b-729caca94efd Q4 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 27478 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2012 fourth_quarter PHA S.1058 and H.R. 1971, the Pharmacy Competition and Consumer Choice Act of 2011; H.R. 1936, the Medicare Access to Diabetes Act of 2011; H.R. 1946, the Preserving Our Hometown Independent Pharmacies Act of 2011; S. 1560, Nursing Home Resident Pain Relief Act of 2011; S. 1699, a bill to reduce the costs of prescription drugs under the Medicare program; S. 296, Preserving Access to Life-Savings Medications Act; Drug Cost Reduction Act; S. 2002 and H.R. 4095, Online Pharmacy Safety Act; SEE ADDENDUM S. 1251, Medicare and Medicaid FAST Act; S. 882, STOP Act; S.319, Pharmaceutical Market Access and Drug Safety Act of 2011; S. 1002, SAFE Doses Act; H.R. 4215, The Medicare Pharmacy Transparency and Fair Auditing Act; Prescription Drug User Fee Act; Pharmaceutical Supply Chain Security Drug Shortages legislation; Prescription drug diversion and abuse; TRICARE Pharmacy Benefit/Provisions for inclusion in the National Defense Authorization Act for FY2013; Medicare Part B Revalidation; Hydrocodone Issues; S. 3376, PACT Act, S. 2467 and S. 3254 and H.R. 4310, he National Defense Authorization Act for FY2013; S. 3604, Improving Dementia Care Treatment for Older Adults Act of 2012; Deficit Reduction Issues Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Personnel Management (OPM),SENATE   320000 0 0 2013-01-17T17:10:06.977000-05:00
1341072 FROGUECLARK, LLC e8c46308-cd1e-46aa-ad02-dbcc8e9207c6 Q4 FROGUECLARK, LLC 400695072 LILLY USA, LLC 2012 fourth_quarter PHA Pharmaceutical issues and Medicaid HOUSE OF REPRESENTATIVES 40000   0 0 2013-01-17T17:48:50.693000-05:00
1341200 KAISER FOUNDATION HEALTH PLAN INC. 6b18fc87-0be7-4a08-ac38-a104dbcbd888 Q4 KAISER FOUNDATION HEALTH PLAN INC. 21027 KAISER FOUNDATION HEALTH PLAN INC 2012 fourth_quarter PHA S 2002 - Online Pharmacy Safety Act: To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of Internet pharmacies. Sponsor: Feinstein (D-CA) Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   310000 0 0 2013-01-17T19:29:00.293000-05:00
1341331 COVIDIEN LP ca34715c-abee-4e7a-a1ee-927395fe8b5a Q4 COVIDIEN LP 319778 COVIDIEN LP 2012 fourth_quarter PHA Issues involving controlled substance and pain and addiction drugs generally; H.R. 2119: Ryan Creedon Act of 2011To amend the Controlled Substances Act to require practitioners to obtain particular training or special certification, approved by the Attorney General, on addiction to and abuse of controlled substances and appropriate and safe use of controlled substances in schedule II, III, IV, or V, and for other purposes; Issues related to acetaminophen. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)   470000 0 0 2013-01-18T08:35:02.197000-05:00
1341342 EISAI INC. 47191148-c5a0-4200-b8aa-b198224bfab6 Q4 EISAI INC. 400321512 EISAI INC. 2012 fourth_quarter PHA Drug issues; FDA-DEA issues Prescription Drug User Fee Act Authorization "Track and Trace" legislation HOUSE OF REPRESENTATIVES,SENATE   380000 0 0 2013-01-18T08:37:06.713000-05:00
1341558 APOTEX CORP. 82824ec3-a6d4-4527-8909-fca9cdd9522d Q4 APOTEX CORP. 310973 APOTEX CORP. 2012 fourth_quarter PHA S. 1882, The Fair and Immediate Release of Generics Act S. 27, The Preserve Access to Affordable Pharmaceuticals Act Actelion Pharmaceutical LTD and Actelion Clinical Research Inc. V. Apotex Inc., Apotex Corp., and Roxane Laboratories Inc. The use of Risk Evaluation and Mitigation Strategies (REMS) by brand drug companies to delay generic competition Establishment of a federal track and trace system for pharmaceuticals Adoption of an electronic labeling system for pharmaceuticals HOUSE OF REPRESENTATIVES,SENATE   90000 0 0 2013-01-18T09:33:42.217000-05:00
1343081 THE PROCTER AND GAMBLE COMPANY de5cf831-5dec-43eb-95de-9162f2bad8f0 Q4 THE PROCTER AND GAMBLE COMPANY 32225 THE PROCTER AND GAMBLE COMPANY 2012 fourth_quarter PHA Dextromethorphan Abuse Reduction; Regulation of OTC drugs, devices and cosmetics; S.3376, Preventing Abuse of Cough Treatments Act of 2012 ; H.R.2359, Safe Cosmetics Act of 2011; H.R.4262, Cosmetics Safety Enhancement Act of 2012; H.R.4395, Cosmetic Safety Amendments Act of 2012; Bureau of Citizenship & Immigration Services (BCIS),Commerce, Dept of (DOC),Commodity Futures Trading Commission (CFTC),Consumer Product Safety Commission (CPSC),Energy, Dept of,Environmental Protection Agency (EPA),Executive Office of the President (EOP),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Intl Trade Administration (ITA),Justice, Dept of (DOJ),Natl Security Council (NSC),Office of Science & Technology Policy (OSTP),Patent & Trademark Office (PTO),Securities & Exchange Commission (SEC),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Treasury, Dept of,U.S. Agency for International Development (USAID),U.S. Customs & Border Protection,U.S. Immigration & Customs Enforcement (ICE),U.S. International Trade Commission (ITC),U.S. Trade Representative (USTR)   1163138 0 0 2013-01-18T12:12:24.073000-05:00
1343244 PRIME THERAPEUTICS 5589a249-7f2d-4316-9ab0-db3a8326f140 Q4 PRIME THERAPEUTICS 400339576 PRIME THERAPEUTICS 2012 fourth_quarter PHA H.R. 1971/S. 1058 - Pharmacy Competition and Consumer Choice Act (pharmacy audits) Proposed rule - Standards Related to Essential Health Benefits Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   170000 0 0 2013-01-18T12:31:41.950000-05:00
1343367 AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS bd764784-716e-48b3-9299-859ce3343fa1 Q4 AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS 1672 AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS 2012 fourth_quarter PHA the Prescription Drug Abuse Prevention and Treatment Act of 2011 (S. 507/H.R. 1925) the Stop Oxy Abuse Act of 2011 (H.R. 1316) the Ryan Creedon Act of 2011 (H.R. 2119) Prescription Drug User Fee Act (PDUFA) reauthorization legislation (H.R. 5651/S. 3187) Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Office of Natl Drug Control Policy (NDCP),SENATE   30430 0 0 2013-01-18T12:47:51.717000-05:00
1343378 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 1649a344-d0e3-4df7-9a1e-58ec29f356b3 Q4 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 26672 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 2012 fourth_quarter PHA S. 27, Preserve Access to Affordable Generics Act S. 31, Prescription Drug and Health Improvement Act of 2011 S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147, Prescription Drug Affordability Act H.R. 741, To amend the Federal Food, Drug and Cosmetic Act to prohibit the marketing of authorized generic drugs H.R. 979, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 1971, Pharmacy Competition and consumer Choice Act of 2011 H.R. 2128, STEAM (Stripping the E-Prescribe Arbitrary Mandates) Act of 2011 S. 1058, Pharmacy Competition and Consumer Act of 2011 S. 1356, Affordable Medicines Utilization Act of 2011 S. 1584, Drug Safety and Accountability Act of 2011 H.R. 3026, Safeguarding America's Pharmaceuticals Act of 2011 S. 2002, To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of Internet Pharmacies S. 3187, FDA Safety and Innovation Act Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Federal Reserve System,Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Justice, Dept of (DOJ),SENATE   440000 0 0 2013-01-18T12:49:58.827000-05:00
1343400 AMERICAN VETERINARY MEDICAL ASSOCIATION e035374d-5158-407c-9891-8bd6b5fdd092 Q4 AMERICAN VETERINARY MEDICAL ASSOCIATION 3630 AMERICAN VETERINARY MEDICAL ASSOCIATION 2012 fourth_quarter PHA H.R. 965/S. 1211 Preservation of Antibiotics for Medical Treatment Act H.R. 1401 Fairness to Pet Owners Act Drug Compounding DEA issues related to transportation of controlled substances Agriculture, Dept of (USDA),Executive Office of the President (EOP),Federal Trade Commission (FTC),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE   140000 0 0 2013-01-18T12:51:07.450000-05:00
1343420 ASSOCIATION FOR ACCESSIBLE MEDICINES e7091dac-d56e-43e8-90c4-9d87d120658c Q4 ASSOCIATION FOR ACCESSIBLE MEDICINES 16032 ASSOCIATION FOR ACCESSIBLE MEDICINES 2012 fourth_quarter PHA FY 2014 Budget, FY 2013 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Authorized Generics, Prescription Drug Importation/Re-Importation, drug shortages, prescription drug abuse and generic drugs H.R. 2182 Generating Antibiotic Incentives Now Act of 2011 H.R. 3026 - Safeguarding America's Pharmaceuticals Act of 2011 H.R. 3839 - Drug Shortage Prevention Act of 2012 H.R. 3988 - Generic Drug and Biosimilar User Fee Act of 2012 H.R. 3995 - Protecting Consumer Access to Generic Drugs Act of 2012 H.R. 4332 - Generic Drug Application Review Fairness Act of 2012 H.R. 5651 - Food and Drug Administration Reform Act of 2012 H.R.6160 - Stop Tampering of Prescription Pills Act of 2012 H.R. 6433 - FDA User Fee Corrections Act of 2012 H.R.6584 - Verifying Authority and Legality In Drug Compounding Act of 2012 H.R.6611 - Patient Access to Drugs in Shortage Act of 2012 H.R.6638 - S.A.F.E. Compounded Drugs Act of 2012 S. 44 Medicare Prescription Drug Negotiation Act S. 296 and H.R.2245 Preserving Access to Life-Saving Medication Act S. 373 Fair Prescription Drug Competition Act S. 1584 - Drug Safety and Accountability Act of 2011 S. 1734 - Generating Antibiotic Incentives Now Act of 2011 S. 2295 - Patient Safety and Generic Labeling Improvement Act S. 2516 - Food and Drug Administration Safety and Innovation Act S. 3187 Food and Drug Administration Safety and Innovation Act S.1855 - Pandemic and All-Hazards Preparedness Act Reauthorization of 2011 Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Congressional Budget Office (CBO),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),Patent & Trademark Office (PTO),SENATE,U.S. Trade Representative (USTR),White House Office   486262 0 0 2013-01-18T12:53:15.770000-05:00
1343752 WINSTON & STRAWN LLP e28c9a1d-a671-43df-9025-b3ab408e4220 Q4 WINSTON & STRAWN LLP 41682 FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC ) 2012 fourth_quarter PHA Represent the client on issues related to assuring a safe, reliable supply of heparin and also on patent matters, including settlements and extensions. HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-01-18T13:37:37.317000-05:00
1343917 AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES 40976e56-cd36-4072-8fd3-9c7316ea5c3d Q4 AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES 2321 AMERICAN FEDERATION OF STATE COUNTY AND MUNICIPAL EMPLOYEES 2012 fourth_quarter PHA Proposals to reduce prescription drug costs in Medicare/Medicaid Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE,White House Office   610000 0 0 2013-01-18T13:52:54.347000-05:00
1343985 MICHAEL L. TINER d97d5ebe-665b-462b-9255-77e7606fbd75 Q4 MICHAEL L. TINER 38175 PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION 2012 fourth_quarter PHA Trans Pacific Partnership, Medicare Part D Rebates HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-01-18T13:57:15.673000-05:00
1344359 TARPLIN, DOWNS & YOUNG, LLC 0a55d618-ccdf-4f68-b1b6-2951c19b15c9 Q4 TARPLIN, DOWNS & YOUNG, LLC 304736 PHRMA 2012 fourth_quarter PHA **see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation ***, no specific bill(s), prescription drug importation, import safety, supply chain integrity, Prescription Drug User Fee Act and associated policies Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2013-01-18T14:23:47.687000-05:00
1344484 MCDERMOTT WILL & SCHULTE LLP f292b676-e3dd-4a51-857b-f8c94e4dc2aa Q4 MCDERMOTT WILL & SCHULTE LLP 24338 ALLERGAN, INC. 2012 fourth_quarter PHA Issues related to Section 340B of the Public Health Service Act; FDA issues; health reform implementation Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2013-01-18T14:35:42.640000-05:00
1344712 AMERICAN PHARMACISTS ASSOCIATION c42e85ed-e289-46ea-b86e-c0383e9b2719 Q4 AMERICAN PHARMACISTS ASSOCIATION 3071 AMERICAN PHARMACISTS ASSOCIATION 2012 fourth_quarter PHA HCR(PL 111-152/111-148) concerning Medicare PartD;MTM;DME;transitions of care;pharmacy reibursement; agency issues concerning risk evaluation mitigation strategies;prescription drug monitoring program,drug abuse,safe drug supply chain;standardized medication action plans;personalized medication lists;ACOs;pharmacists role in CMS Innovation Center initiatives;immunization;HIT; medication disposal;biosmiliars;EHB; compounding;SGR Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-01-18T14:52:15.687000-05:00
1344836 ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 0ac1bacf-62f5-4d98-a4cd-087dc0efe677 Q4 ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 58534 ATRIUM HEALTH - FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 2012 fourth_quarter PHA H.R. 2674 Supprotive of any language that amends section 340B of the Public Health Service Act to revise and expand the drug discount program under that section to improve the provision of discounts on drug purchases for certain safety net providers by expanding 340 B discoutns to inpatient settings. HOUSE OF REPRESENTATIVES,SENATE   12856 0 0 2013-01-18T15:01:16.653000-05:00
1344944 TARPLIN, DOWNS & YOUNG, LLC 54060356-5733-4454-ad16-c17845fd61d2 Q4 TARPLIN, DOWNS & YOUNG, LLC 304736 ASTRAZENECA 2012 fourth_quarter PHA **see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act H.R. 2182/S. 1734 - Generating Antibiotics Incentives Now Act PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation ***, no specific bill(s), Import Safety, Prescription Drug User Fee Act renewal, drug development policy, drug shortages, supply chain integrity, patent settlements Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2013-01-18T15:10:12.193000-05:00
1344979 AMERICAN ACADEMY OF FAMILY PHYSICIANS fdee3e19-ebe9-41ce-b0af-31e99c1957c5 Q4 AMERICAN ACADEMY OF FAMILY PHYSICIANS 1342 AMERICAN ACADEMY OF FAMILY PHYSICIANS 2012 fourth_quarter PHA No Bill Number, Briefing on ONDCP/NIDA e-Learning tools on opioid prescribing, monitor federal activities on tools for prescribers, support policies which do not burden family physicians. No Bill Number, Meeting with ONDCP director to eliminate CME mandates from National Drug Control strategy. No Bill Number, Prescription Drug Abuse, Support for national database and opposition to mandated CME. No Bill, National Drug Control Strategy announcement, New CME for prescribers of opioid analgesics, Support drug control policies which are not burdensome to family physicians. Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),Office of Natl Drug Control Policy (NDCP),SENATE,Veterans Affairs, Dept of (VA),White House Office   633350 0 0 2013-01-18T15:11:23.627000-05:00
1345229 TARPLIN, DOWNS & YOUNG, LLC 511eadad-5ed3-4357-92b9-34d7dce0ec06 Q4 TARPLIN, DOWNS & YOUNG, LLC 304736 BIOTECHNOLOGY INDUSTRY ORGANIZATION 2012 fourth_quarter PHA **see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act S. 296 - Drug Shortage Act PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, PDUFA and associated policies, patent settlements, accelerated approval, break through therapies Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2013-01-18T15:27:05.300000-05:00
1345306 MCDERMOTT WILL & SCHULTE LLP 892a78d0-f18a-448c-a2c6-3a83eee7ee35 Q4 MCDERMOTT WILL & SCHULTE LLP 24338 RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION 2012 fourth_quarter PHA Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2013-01-18T15:33:36.940000-05:00
1345392 BAYER CORPORATION (CONSOLIDATED REPORT) 5dba645e-9c95-4d48-bf53-56f5501641ca Q4 BAYER CORPORATION (CONSOLIDATED REPORT) 5632 BAYER CORPORATION (CONSOLIDATED REPORT) 2012 fourth_quarter PHA H.R. 4223 the "Safe Doses Act"; H.R. 3668 the "Counterfeit Drug Penalty Enhancement Act of 2011"; and H.R. 4216 the "Foreign Counterfeit Prevention Act.", all parts Combat Meth epidemic Act of 2005, sections pertaining to electronic reporting and stop sale Meth Lab Elimination Act of 2010, a draft by Sen. Wyden, all parts relating to pseudoephedrine HOUSE OF REPRESENTATIVES,SENATE   1150000 0 0 2013-01-18T15:42:17.393000-05:00
1345524 UNIVERSITY OF CONNECTICUT a45a14fa-9305-4b80-a647-c9a5c7961f68 Q4 UNIVERSITY OF CONNECTICUT 39382 UNIVERSITY OF CONNECTICUT 2012 fourth_quarter PHA Issues related to FDA salaries and expenses; and extramural research: S.2375/H.R.5973, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2013 Public Law 112-55, Consolidated and Further Continuing Appropriations Act, FY2012 Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE   70000 0 0 2013-01-18T15:52:05.597000-05:00
1345967 WALGREEN COMPANY cebf413a-c817-4673-bd7b-e1f1628fbd02 Q4 WALGREEN COMPANY 309071 WALGREEN COMPANY 2012 fourth_quarter PHA H.R. 1971/S. 1058 - the "Pharmacy Competition and Consumer Choice Act of 2011," all provisions related to requirement of Pharmacy Benefit Managers annual reporting to Part D plan sponsors of number and total cost of prescriptions under a contract, payments to pharmacies, payments from pharmaceuticals manufacturers and generic and brand name drugs dispensed. H.R. 4215 - the "Medicare Pharmacy Transparency and Fair Auditing Act," amends Medicare Part D to require each contract entered into with a prescription drug plan (PDP) sponsor for the offering of a prescription drug plan to prohibit PDP sponsor from contracting with any pharmacy benefits manager (PBM) to manage the prescription drug coverage under such plan or control the costs of such coverage, unless the manager satisfies specific PBM audit and disclosure requirements. H.R. 6638, the Supporting Access to Formulated and Effective (SAFE) Compounded Drugs Act, all provisions requiring compounding pharmacies to register their facility with the FDA, requiring compounded drugs to be labeled appropriately, establishing an FDA database on compounding pharmacies and having the FDA set minimum production standards. Issues relating to regulations that would establish an effective drug identification and tracking system through which drug manufacturers, repackagers, wholesale distributors and dispensers may authenticate the wholesale distribution history of any prescription drug that is subject to a requirement for a standardized numerical identifier. No specific legislation. HOUSE OF REPRESENTATIVES,SENATE   790000 0 0 2013-01-18T16:17:57.993000-05:00
1346086 THE SMITH-FREE GROUP, LLC c5214852-0ffe-4c2d-9da3-da554a1bbcfa Q4 THE SMITH-FREE GROUP, LLC 35800 HCA 2012 fourth_quarter PHA Monitor Senate and House inquiry into compounding pharmacy Federal/State regulatory regime HOUSE OF REPRESENTATIVES,SENATE 110000   0 0 2013-01-18T16:27:46.597000-05:00
1346176 ACADEMY OF MANAGED CARE PHARMACY cfaed41c-57f5-4a82-b23e-03b0710882ae Q4 ACADEMY OF MANAGED CARE PHARMACY 48793 ACADEMY OF MANAGED CARE PHARMACY 2012 fourth_quarter PHA S 27 - legislation that would authorize the Federal Trade Commission to presume illegal agreements between manufacturers of innovator and generic pharmaceutical products in which the generic manufacturer agrees to delay entry into the market in exchange for compensation from the manufacturer of the innovator product; HR 2746 - legislation that would require cost-sharing parity between all cancer medication within pharmacy benefits regulated under ERISA; HR 979 - legislation that would implement transparency standards and other regulations for pharmacy benefit managers working within the Federal Employees Health Benefits Program; HR 4209 - legislation that would require individual and group health insurance policies covered under ERISA and which use a formulary for prescription drug coverage to charge the same co-payments/co-insurance rate for specialty drugs as the co-payments/co-insurance rate for non-preferred brand drugs; HR 1971/S 1058 - legislation that would impose transparency and audit requirements for PBMs contracting with group health plans; HR 6584 - legislation that would impose federal requirements on compounding pharmacies HOUSE OF REPRESENTATIVES,SENATE   170000 0 0 2013-01-18T16:36:18.287000-05:00
1346518 BROWN RUDNICK LLP c3fad43c-d400-4556-861e-3be1b880c455 Q4 BROWN RUDNICK LLP 287895 HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC 2012 fourth_quarter PHA H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 1065 & S. 1760- Pill Mill Crackdown Act of 2011; S.2297 relating to hydrocodone rescheduling. H.R. 5853 - Gray Market Drug Reform and Transparency Act of 2012 HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2013-01-18T17:04:50.850000-05:00
1346544 CVS HEALTH (AND SUBSIDIARIES) 383efec4-6fad-4061-90cb-dbe409ef4f6b Q4 CVS HEALTH (AND SUBSIDIARIES) 302778 CVS CAREMARK INC 2012 fourth_quarter PHA Issues related to prescription drug abuse, drug supply chain safety and prescriber education. HR 2119 Ryan Creedon Act of 2011 HOUSE OF REPRESENTATIVES,SENATE,White House Office   2930000 0 0 2013-01-18T17:05:57.520000-05:00
1347133 BGR GOVERNMENT AFFAIRS 25f16ead-3445-4850-84b9-d5e9b49b62e2 Q4 BGR GOVERNMENT AFFAIRS 5357 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2012 fourth_quarter PHA HCR implementation; PDUFA reauthorization; Part D; patent reform Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2013-01-18T19:57:39.443000-05:00
1347210 THORN RUN PARTNERS f6f3b96f-c6d9-4f0c-9ba0-7f5a410631f7 Q4 THORN RUN PARTNERS 400534596 LONG TERM CARE PHARMACY ALLIANCE 2012 fourth_quarter PHA S.1560, Nursing Home Resident Pain Relief Act of 2011; issues related to the implementation of the Affordable Care Act (ACA), DEA enforcement of controlled substances in nursing homes and the practice of consultant pharmacy; issues related to PDUFA including Senate amendment on hydrocodone abuse; H.R.4215, Medicare Pharmacy Transparency and Fair Auditing Act. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2013-01-18T22:49:33.400000-05:00
1347686 THE INGRAM GROUP LLC 751ebd2d-e086-4c61-8bff-ca32dd4edd63 Q4 THE INGRAM GROUP LLC 400577737 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2012 fourth_quarter PHA Issues related to pharmaceutical importation, generic drug pricing and the FAIR Generics Act, S.1882. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2013-01-19T22:13:20.820000-05:00
1347946 SQUIRE PATTON BOGGS bbb63dd0-bc3c-405f-b157-baebef8d0732 Q4 SQUIRE PATTON BOGGS 30906 RANBAXY INC. 2012 fourth_quarter PHA S. 27, Preserve Access to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of P.L. 111-148, Patient Protection & Affordable Care Act; Prescription Drug User Fee Reauthorization issues; H.R. 8, the American Taxpayer Relief Act. HOUSE OF REPRESENTATIVES,SENATE 180000   0 0 2013-01-20T04:25:12.937000-05:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2506.619ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API